Phenothiazine-Tacrine Heterodimers: Pursuing Multitarget Directed Approach in Alzheimer's Disease.
Alzheimer’s disease
acetylcholinesterase
butyrylcholinesterase
multitarget directed ligands
phenothiazine
tacrine
Journal
ACS chemical neuroscience
ISSN: 1948-7193
Titre abrégé: ACS Chem Neurosci
Pays: United States
ID NLM: 101525337
Informations de publication
Date de publication:
05 05 2021
05 05 2021
Historique:
pubmed:
15
4
2021
medline:
22
6
2021
entrez:
14
4
2021
Statut:
ppublish
Résumé
Since 2002, no clinical candidate against Alzheimer's disease has reached the market; hence, an effective therapy is urgently needed. We followed the so-called "multitarget directed ligand" approach and designed 36 novel tacrine-phenothiazine heterodimers which were
Identifiants
pubmed: 33852284
doi: 10.1021/acschemneuro.1c00184
doi:
Substances chimiques
Amyloid beta-Peptides
0
Cholinesterase Inhibitors
0
Phenothiazines
0
Tacrine
4VX7YNB537
Acetylcholinesterase
EC 3.1.1.7
Butyrylcholinesterase
EC 3.1.1.8
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM